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Abstract 
Background: Although China has a long history of using acupoints herbal patching (acupoints herbal patching 
means applying herbal patch on special acupoints to stimulate skin to form blisters, hyperemia, and even suppura-
tion) in Sanfu Days (Sanfu Days are supposed to be the three hottest days in a year which is calculated by the ancient 
calendar) for the treatment of asthma, there is insufficient evidence to support its effectiveness and safety issues. This 
study investigated the efficacy and safety of acupoints herbal patching compared with placebo in participants with 
asthma in clinical remission stage.
Methods: We enrolled participants with asthma in clinical remission stage, above 13 years old and both genders in 
a randomized, double-blind and placebo-control trial at clinical center, School of Chinese Medicine, The University 
of Hong Kong to assess the effectiveness and safety of acupoints herbal patching, as compared with placebo, when 
added to guidelines-based therapy. The trial was conducted for three times (these three times were 19 July, 29 July 
and 8 August 2010), and the primary outcome was pulmonary function test. Secondary outcome was self-made 
questionnaire which were designed based on Traditional Chinese Medicine theory and clinical experience summary.
Results: Three hundred and twenty three eligible participants were enrolled, they were randomly assigned to 
acupoints herbal patching group (n = 165), placebo control group (n = 158). There was no significant difference 
in primary and secondary outcome as compared with placebo group at the end of 3rd treatment and four times 
follow ups. But sub-analysis of secondary outcome in four times follow ups showed that acupoints herbal patching 
significantly reduced the proportion of participants who didn’t need medical treatment when they had a small rise in 
asthma-related symptoms increased from 6–15 % at 1st follow up and 0–7 % at 3rd follow up (P < 0.05). It indicated 
that the proportion of participants who can spontaneous resolution of an asthma attack increased through acupoints 
herbal patching. In addition, acupoints herbal patching was significantly superior to placebo in reducing the percent-
age of participants who were susceptibly waken up by asthma symptoms from 27–14 %, and the percentage of par-
ticipants who had the symptom of running nose and sneezing before onset from 18–8 % at 2nd follow up (P < 0.05). 
Improvements also occurred with treatment group, it reduced the proportion of participants who were spontaneous 
sweating at 3rd follow up (P < 0.05).
Conclusions: There was no significant difference between acupoints herbal patching and placebo in pulmonary 
function test in this study. Self-made questionnaire showed that the lasting effect of acupoints herbal patching was 
significantly better than placebo in reducing the need for medications to control asthma and the proportion of sus-
ceptible symptoms in participants with asthma in clinical remission stage. It showed that the low quality of life caused 
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Background
Asthma is a clinical syndrome of unknown etiology that 
diagnosed on the basis of symptoms including wheeze, 
dyspnoea, and cough, etc, accompany with the objec-
tive evidence of airflow obstruction [1]. Currently, 
β-agonists still as the first-line drug in treating acute 
asthma attack and glucocorticoids used to treat chronic 
asthma while are associated with various adverse effects 
[2–10]. In china, there was a long history of using acu-
points herbal patching in Sanfu Days for preventing and 
treating asthma. Sanfu Days are calculated by Heavenly 
Stems and Earthy Branches which are supposed to be the 
three hottest days in a year. According to the provision, 
the third and fourth Gengri after the summer solstice is 
recorded as the first and second hottest days, and the first 
Gengri after the beginning of autumn is recorded as the 
third hottest day. In these days, body’s Yang-qi (positive 
energy) has an exuberant trend with the aid of Yang-qi 
developed by nature, and the Cold-qi in the body also in 
the condition of easily dissolve. Acupoints herbal patch-
ing means applying medicinal cakes which are made of 
Chinese herbs on special acupoints. These herbs are pun-
gent in flavor, warm in property, and have the function of 
dredging the channel, which can stimulate skin to form 
blisters, hyperemia and even suppuration. As a result, 
acupoints herbal patching combined with Sanfu Days 
get a purpose of adjusting Yin and Yang, preventing and 
curing diseases, and enhancing body resistance through 
acupoints stimulation and drug infiltration absorption. 
In modern terms, acupoints herbal patching is similarly 
to transdermal drug delivery. Many Chinese scientists 
have already conducted some animal and clinical stud-
ies on the efficacy of acupoints herbal patching for the 
treatment of asthma. So far, they found that acupoints 
herbal patching was effective in improving lung func-
tion and syndromes in participants with asthma not only 
from animal studies but also clinical studies [11–19]. But 
the weakness of previous clinical studies, such as poor 
methodologically, small sample size, short follow-up, 
didn’t mention whether get Institutional Review Board 
(IRB) approval before study, also not mentioned drop-
out rate and safety issue, all these make people uncon-
vinced of the previous findings [20–22]. Hence, this study 
tried to design a more rigorous, bigger sample size and 
longer follow-up clinical randomized control trial (RCT) 
aim to investigate the efficacy and safety of acupoints 
herbal patching compared with placebo. The hypothesis 
of this study was that there was no significant difference 
between acupoints herbal patching group and placebo 
group in preventing and reducing the frequency and 
severity of asthmatic attacks.
Methods
Participants
This study was a randomized, double-blind, placebo-
controlled trial in 323 asthma participants in clinical 
remission stage (above 13 years old and in both genders). 
The diagnose standard of asthma in clinical remission 
stage means participants had a history of asthma attack 
in the past 12  months, but asthma-related signs and 
symptoms disappeared, pulmonary function recover to 
the level before acute asthma attack and maintain more 
than 3 months when they entered this study. Documen-
tation of symptoms of asthma or a physician’s diagnosis 
of asthma for more than 1 year preceding the study visit 
was required. Participants need to meet the inclusion cri-
teria listed as follow: symptoms occurring or worsening 
at night, episodic symptoms of airflow obstruction; dif-
ficulty breathing, chest tightness, cough (worse at night); 
symptoms awakening the patient, occurring or worsening 
with exercise; viral infections, and changes in weather.
Participants would be ineligibility if they meet one or 
more following exclusion criteria: acute asthma attack, 
fever and pharyngitis, pregnancy, tuberculosis, severe 
cardiac and pulmonary diseases. Participants were also 
excluded if they had diabetes mellitus, allergy to topical 
medication and hypersensitive skin condition. Additional 
exclusion criteria were bleeding disorders, severe heart 
diseases or with pacemaker and keloid.
The study protocol (21006030HA) was approved by 
the Institutional Review Board of the University of Hong 
Kong/Hospital Authority Hong Kong West Cluster 
(HKU/HA HKWC IRB) with coding UW 10-274. This 
clinical trial was authorized by Clinical Trials Centre of 
The University of Hong Kong (HKUCTR-1128). URL of 
register can be found in http://www.hkuctr.com/Study/
Show/f5d04b243cb14c25b9033ec55e96f6f5. Grants from 
Hospital Authority (No.200006030). All study partici-
pants need to provide written informed consent, those 
younger than 18 years of ages were also required to pro-
vide assent and then signature by their parent or legal 
guardian.
by asthma-related symptoms was significantly improved through acupoints herbal patching in Sanfu Days. Besides, 
acupoints herbal patching was as safe as placebo for chronic stable asthma.
Trial registration number: HKUCTR-1128, Registration date 22 Jul 2010
Keywords: Asthma, Randomized trial, Acupoints herbal patching, Sanfu days
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Procedures
After screening visit, enrolled participants were ran-
domly assigned to an acupoints herbal patching group 
and a placebo control group by a third person (Wang ZH) 
and she did not practice throughout the study. Random 
numbers were distributed by the formula of [=  rand ()] 
in Microsoft Office Excel 2007 (fraction between 0 and 
1), and if the produced random number  ≥0.5, it was 
assigned to acupoints herbal patching group, and oth-
erwise, it was belonged to placebo group. The principal 
investigator of this study—Dr. Li L, who obtained Ph.D. 
degree of acupuncture and moxibustion and have more 
than 30  years acupuncture clinical experience. Besides 
he is not only the registered Chinese Medicine practi-
tioner in Mainland China, but also Hong Kong registered 
Chinese Medicine practitioner. The rest practition-
ers who participated in this study all have bachelor or 
bachelor above degree of Traditional Chinese Medicine 
(TCM), and all of them are registered Chinese Medicine 
practitioners.
A study coordinator (Choi PY) allocated the random 
numbers to participants. Regarding as the allocation 
results, they were sealed into opaque envelopes and allo-
cation concealment must be warranted. Totally twelve 
medical beds were provided during these three treatment 
days and treatment hours were from 9  a.m. to 7  p.m. 
During the treatment days, one usher (totally ten ushers 
who were Li XZ, Ching WT, Yau T, Zhang WD, Tse WM, 
Wu TT, Kan WY, Lo MF, Shi HF and Irene) guided one 
patient to the reception room, and then the receptionist 
(totally two receptionist: Leung LF and Lam CK) checked 
the random numbers list to decide which kind patch was 
given for this participant and told the result to taking 
patch person (totally two taking patch person: Lam WC 
and Chia KL). Then taking patch person took a sealed 
box with eleven patches inside to plaster (totally 10 plas-
ters: Li L, Chan WC, Lo KC, Zhang W, Eric Z, Wong V, 
Tin PY, Chan HN, Cheung SK and Choi WF). Plaster 
spent nearly 5 min to paste patches in acupoints (totally 
11 acupoints, and one patch for one acupoints), and then 
plaster used approximately 4 cm × 4 cm hypoallergenic 
tape (3  M™ Micropore™ Tape 1535-3) to stick patches 
in skin. Then the usher took the participant to waiting 
room, research assistants (Wu FM and Cheung CY) in 
waiting room removed the patches after 2  h. Last, par-
ticipants can leave treatment place if they didn’t have any 
uncomfortable. During the whole process, nobody has 
idea of which treatment they have been received or given 
except Wang ZH. Until final statistic finished, Wang ZH 
managed unblinding and the random code was broken.
Both the acupoints herbal patching and placebo treat-
ment was consisted of three sessions with 2  h duration 
(these three sessions were 19 July, 29 July and 8 August 
2010). For all participants, 11 acupoints were applied by 
patches: Du14, Du12, Du4, BL13 (both side), BL23 (both 
side), BL43 (both side) and EX-B1 (both side) (Fig.  1). 
In both groups, every selected acupoints was applied 
one patch and every patch was about 2  g (Fig.  2). The 
final formula used in treatment group was a combina-
tion of the record in the “Zhang’ Medicine” and the for-
mula frequency used in clinical trials. In the acupoints 
herbal patching group, the selected herbals were Sinapi 
Alba, Radix Corydalis Yanhusuo, Processed Euphorbia 
kansui, Asari Herba cum Radice, Ephedrae Herba, Pro-
cessed Radix Aconiti Praeparata, Cinnamomum cas-
sia and Eugenia caryophyllata, with a proportion in 
2:1:1:1:1:1:1:1. At last, these herbals were mixed together 
with ginger juice. In placebo group, the selected materi-
als with a proportion of 3:3:1 including pure starch, red 
rice and black glutinous rice, which finally were mixed 
together by petroleum jelly (Fig. 3).
All participants completed the self-made question-
naires and pulmonary function test at baseline, the end 
of 3rd treatment, and four times follow ups (Fig.  4). 
Questionnaires were assessed by physicians (Li L, Chan 
Fig. 1 Acupoints
Fig. 2 Herbal patch
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WC, Lo KC, Zhang W, Eric Z, Wong V, Tin PY, Chan 
HN, Cheung SK and Choi WF) through face to face. The 
primary outcome was pulmonary function test: forced 
expiratory volume in one second (FEV1) and forced 
expiratory volume in one second/forced vital capacity 
[FEV1/FVC (%)], the pulmonary function test machines 
were provided by the lab in School of Chinese Medicine, 
The University of Hong Kong and all operators didn’t 
know they do lung function test for which group partici-
pants. Secondary outcome was self-made questionnaire 
which included the number of days with asthma-related 
symptoms, asthma-related health care use, the frequency 
of bronchodilator used during asthma attack, the num-
ber of asthma related symptoms which were associated 
with Chinese Medicine and the percentage of partici-
pants with twenty-three specific such symptoms. These 
twenty-three symptoms were shown in Table 2.
Statistical analysis
The participants who received at least baseline assess-
ment constituted the intention-to-treat (ITT) analysis, 
with a two-sided alpha level of 0.05. For all primary and 
secondary outcome measures, sensitivity analyses were 
performed by replacing missing data with the last value. 
An additional per-protocol analysis (PP) was carried out 
for participants without major protocol violation who 
could be assessed at the end of 3rd treatment. Statisti-
cal analyses were performed with the Statistical Package 
for the Social Sciences (SPSS) software program (version 
19) for Windows XP. The analysis included data from 
week 0 (baseline) through week 8 (at the end of 3rd treat-
ment) and was performed with the use of an analysis of 
covariance (ANCOVA), group (acupoints herbal patch-
ing group and placebo group) as a fixed factor and time 
as covariance (baseline as the 1st time, post-treatment as 
the 2nd time). ANCOVA was conducted for continuous 
variables such as the number of asthma related symp-
toms which were associated with Chinese Medicine, 
the number of days with asthma-related symptoms and 
pulmonary function test: FEV and FEV1/FVC (%) [23]. 
Binary logistic regression was conducted for the cat-
egorical variable such as asthma-related health care and 
the percentage of participants with twenty-three specific 
such symptoms [24]. Non-parametric test was conducted 
for a ranked variable such as the frequency of bronchodi-
lator used during asthma attack. For the 1st, 2nd 3rd and 
Fig. 3 Acupoints herbal patching schematic diagram
Fig. 4 Study design
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4th follow up measurements, two-sided t tests and Chi-
square tests were done for groups’ pair wise comparisons 
[23]. Sample size was calculated according to the effec-
tive rate that conducted by previous clinical trials of acu-
points herbal patch for asthma. The no. of target subjects 
to be recruited at local site was 380 (190 per treatment 
group × 2 groups) through statistic.
Results
Enrollment
Initially, 451 participants with asthma in clinical remis-
sion stage applied to participate in this project. Figure 5 
shows the trial flow. After screened, 323 participants 
underwent randomization: 165 to acupoints herbal 
patching group and 158 to placebo group. All subjects 
(323) were included in the ITT population. Forty-two 
participants in acupoints herbal patching group and 
thirty-nine participants in placebo group stopped the 
treatment prematurely. A PP analysis was conducted for 
the 242 subjects who could be assessed at the end of the 
3rd treatment.
Tables 1, 2 showed the baseline characteristics of par-
ticipants in the two study groups and their characteris-
tics were basically similar: for both groups, the average 
age was 44  years old, 44  % were male, and the average 
disease course of asthma were 22.74 ± 22.68 year in pla-
cebo group and 21.13 ±  21.08  year in acupoints herbal 
patching group. At enrollment, regarding the number of 
days on which subjects had asthma-related symptoms in 
acupoints herbal patching group was 10.25 ± 12.26 and 
7.97 ± 10.94 in the placebo group. The mean (±SD) FEV1 
was 2.13 ± 1.08 in acupoints herbal patching group and 
2.07 ± 1.00 in placebo group, and the mean ratio of FEV1 
to FVC was 85.97 ± 13.85 in acupoints herbal patching 
group and 86.25 ± 13.93 in placebo group. Regarding the 
health care used when they had a small rise in asthma-
related symptoms, no difference occurred in treatment 
group and control group. Besides, there was nothing 
different between acupoints herbal patching group and 
placebo group in the distribution of the frequency of 
bronchodilator used during asthma attack in previous 
1  year. Additionally, the number of symptoms which 
were associated with Chinese Medicine was also nearly 
same (9.12 ± 4.28 in TG, 9.22 ± 4.18 in CG). There was 
also nothing different in percentage of participants with 
twenty-three specific such symptoms between acupoints 
herbal patching group and placebo group.
Response to intervention
After three times acupoints herbal patching, as compared 
with placebo, no changes occurred in primary outcome 
at the end of the 3rd treatment and four times follow ups 
(Tables  1, 3). Also, there was no significant difference 
appeared in secondary outcome at the end of the 3rd 
treatment (Table  2). But sub-analysis of secondary out-
come in the following four times follow ups was found 
that acupoints herbal patching was superior to placebo 
in improving certain symptoms (Table  4). The result of 
sub-analysis show that acupoints herbal patching signifi-
cantly reduced the proportion of participants who didn’t 
need medical treatment when they had a small rise in 
asthma-related symptoms increased from 6–15  % com-
pared with placebo group at the 1st follow up (Nov), and 
increased the proportion from 0–7 % at the 3rd follow up 
(May) (Fig. 6, all P < 0.05). In other words, the proportion 
of participants who can spontaneous resolution of an 
asthma attack increased through acupoints herbal patch-
ing. Additionally, acupoints herbal patching as compared 
with placebo group significantly reduced the percentage 
of participants who are susceptibly waken up by asthma 
symptoms from 27–14 % at 2nd follow up (Feb) (Fig. 7, 
P  <  0.05). Similarly, acupoints herbal patching signifi-
cantly reduced the proportion of participants who had 
the symptom of running nose and sneezing before onset 
from 18–8 % at 2nd follow up (Fig. 8, P < 0.05). Improve-
ments also occurred with acupoints herbal patching 
group, it reduced the proportion of participants who 
were spontaneous sweating at 3rd follow up and diarrhea 
after intake of oily food at 4th follow up (Figs. 9, 10, July, 
all P < 0.05). All these findings showed that the low qual-
ity of life that caused by asthma-related symptoms was 
significantly improved through acupoints herbal patching 
in Sanfu Days. The top four symptoms which improved 
mostly in asthma participants were: susceptibly waken up 
by asthma symptoms and running nose, sneezing before 
onset which were belong to Lung-qi-deficiency; spon-
taneous sweating and diarrhea after intake of oily food 
were belong to Spleen-qi-deficiency. It showed that acu-
points herbal patching has a better effect for those partic-
ipants who were Lung-qi-deficiency and mainly showed 
as susceptibly waken up by asthma symptoms and run-
ning nose, sneezing before onset, and Spleen-qi-defi-
ciency which mainly showed as spontaneous sweating 
and diarrhea after intake of oily food. Last but not least, 
the results of PP analysis were consistently with the ITT 
analysis.
Safety
Cutaneous reaction such as itching, skin warm feeling, 
swollen, blisters or pain were seen in almost all partici-
pants from acupoints herbal patching group. Participants 
in placebo group only have minor skin redness during the 
treatment. All these cutaneous reaction disappeared once 
stopped treatment. Five severe adverse events reported 
in treatment group: three participants appeared asthma 
exacerbation, one subject tended to vomited blood and 
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451 participants screened
128 excluded
111 did not perform study procedures 
according to the appointment time
17 exclusionary medical histories323 participants randomly assigned
165 assigned to treatment group 158 assigned to control group
1 refused to participate after randomization
29 incomplete treatments
8 lost to follow-up
2 incomplete data
2 illnesses 
123 completed treatment and post-assessment
1 illness
5 incomplete data
10 lost to follow-up
20 incomplete treatments
3 refused to participate after randomization
119 completed treatment and post-assessment
3 refused to participate 
1 did not in Hong Kong
7 lost to follow-up
1 ineffective treatment 
1 unable to participate on time
1 illness 
4 others
105 participated at 1st follow up
4 refused to participate 
6 did not in Hong Kong
1 ineffective treatment
4 lost to follow up
1 illness 
2 others
101 participated at 1st follow up
1 illness 
1 refused to participate 
3 unable to participate timely 
8 lost to follow up
1 refused to participate
3 illnesses
3 unable to participate timely
6 lost to follow up
92 participated at 2nd follow up 88 participated at 2nd follow up
1 asthma exacerbation
2 incomplete data
6 unable to participate timely
9 lost to follow up
74 participated at 3rd follow up
1 incomplete data
3 unable to participate timely
21 lost to follow up
63 participated at 3rd follow up
60 participated at 4th follow up
1 refused to participate
4 lost to follow up
4 unable to participate timely
5 others
54 participated at 4th follow up
4 unable to participate timely
1 incomplete data
4 others
Fig. 5 Trial flow
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automatically stopped after the 2nd acupoints herbal 
patching and had confirmed that has nothing to do with 
acupoints herbal patching, and one participants appeared 
the rash due to allergic to acupoints herbal patching 
patch. In addition, one participant has confirmed that she 
was pregnancy at the end of July 2010.
Discussion
In this study, participants with asthma in clinical remis-
sion stage who received acupoints herbal patching had no 
significant difference in primary and secondary outcomes 
at the end of 3rd treatment comparing with placebo 
group. Although ANCOVA show an insignificant effect 
of group (P  >  0.05), the effect of time was significant 
(P < 0.001). This indicated that both groups experienced 
similar improvement, including significant decrease in 
the number of symptoms which were associated with 
Chinese Medicine, the percentage of participants with 
twenty-three symptoms which were associated with Chi-
nese Medicine, the number of days with asthma related 
symptoms, etc. Only from the result of 3rd treatment, 
acupoints herbal patching seemed to be equal to the 
function of placebo, while rethinking its concept of acu-
points herbal patching in Sanfu Days which means past-
ing herbal patch on some special acupoints in Sanfu Days. 
In others words, acupoints herbal patching in Sanfu Days 
Table 1 Characteristics of study participants before and after treatment
Plus-minus value are mean ± SD. P values for the comparison of means and percentages were calculated with the use of Chi-square test for categorical variables and 
the independent-samples test for continuous variables. FEV1, FVC
a The number of days with symptoms was calculated as the largest of the following variables during the previous 1 month: the number of days with wheezing, cough, 
chest tightness, or nighttime sleep disruption. This symptom scale ranges from 0–30 days
b Accident and emergency departments (A and E)
c The total number of symptoms which frequently appeared in asthma participants are 23
Variable Before treatment After treatment
Acupoints herbal  
patching mean (SD)
Placebo  
mean (SD)
P Acupoints herbal  
patching mean (SD)
Placebo mean 
(SD)
P
Age–year 44.28 ± 17.15 44.53 ± 17.83 0.90
Gender—no. (%)
 Male 73 (44.24) 69 (43.67) 0.92
 Female 92 (55.76) 89 (56.32)
Duration of asthma—year 21.13 ± 21.08 22.74 ± 22.68 0.51
Asthma-related symptoms—no. of 
days in previous 1 yeara
10.25 ± 12.26 7.97 ± 10.94 0.08
Asthma-related symptoms—no. of 
days during the treatment
2.58 ± 0.47 2.68 ± 0.48 0.88
Lung function
 FEV1 2.13 ± 1.08 2.07 ± 1.00 0.57 2.04 ± 0.41 2.12 ± 0.42 0.14
 FEV1: FVC × 100 85.97 ± 13.85 86.25 ± 13.93 0.86 87.36 ± 0.66 87.20 ± 0.67 0.87
Asthma-related health care use—no. (%)
 ≥1 admit to A&Eb 48 (29) 46 (29) 1.00 4 (3) 3 (3) 0.73
 ≥1 hospitalization 26 (16) 29 (18) 0.54 3 (2) 2 (2) 0.68
 ≥1 outpatient visit 134 (81) 134 (84) 0.39 13(12) 14 (12) 0.77
 ≥1 prescription 139 (84) 136 (86) 0.64 65 (53) 57 (48) 0.44
 ≥1 by own medication 34 (21) 24 (15) 0.21 2 (2) 2 (2) 0.97
 ≥1 didn’t need treatment 26 (16) 17 (11) 0.19 8 (7) 6 (5) 0.63
The frequency of bronchodilator during asthma attack—no. (%) 0.21 0.72
More than twice per day 37 (22) 29 (18) 13 (11) 13 (11)
Once to twice per day 50 (30) 62 (39) 34 (28) 33 (28)
2–3 times per week 12 (7) 18 (11) 3 (2) 2 (2)
Less than once per week 48 (29) 36 (23) 13 (11) 7 (6)
Never 18 (11) 13 (8) 60 (49) 64 (54)
Symptoms which frequently 
appeared in asthma participants—
no. of symptomsc
9.12 ± 4.28 9.22 ± 4.18 0.83 3.92 ± 0.34 4.01 ± 0.37 0.85
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take effect in the treatment of asthma need three factors: 
the first is time (Sanfu Days), the second is meridian effi-
cacy and the third is special herbal patch. In this study, 
placebo group also conducted in Sanfu Days and placebo 
patches were applied in same acupoints which means 
placebo group occupied two key factors. Hence, placebo 
group also can get an immediate improvement due to the 
psychological effect, time effect and meridian effect. So if 
only from the immediately result of both group at the end 
of 3rd treatment, there was nothing different occurred 
between acupoints herbal patching group and placebo 
group. On the whole, primary and secondary outcomes 
were insignificant different between treatment and con-
trol group, but the sub-analysis of secondary outcome in 
the 1st follow up show that the proportion of participants 
who did not need medical treatment when they had a 
small rise of asthma-related symptoms was 15 % in acu-
points herbal patching group better than 6 % in placebo 
group (P  <  0.05). Winter and seasonal change was the 
peak time point for asthma attack in both groups accord-
ing to the asthma attacks time distribution diagram of 
these 323 participants (Fig.  11). The 1st follow up was 
conducted in November in Hong Kong and it was a time 
from autumn to winter when asthma was easily attacked. 
It indicated that treatment group participants have a 
stronger resistance to asthma than placebo group during 
season change after one course acupoints herbal patch-
ing. Besides, acupoints herbal patching was a preventive 
treatment for asthma.
This study is, to date, the first RCT to compare acu-
points herbal patching with placebo therapy for asthma 
in clinical remission stage. Its strengths included big sam-
ple size, long follow-up and strict blinding. Two inevi-
table limitations were the self-made questionnaire and 
imperfect blinding. There was no doubt that this study 
should adopt the international accepted questionnaire 
for clinical trial on asthma. But this project was full of 
Traditional Chinese Medicine Theory characteristic so 
it needed a questionnaire which combined Traditional 
Chinese Medicine with modern medicine well. So far, 
there was not related questionnaire that was the reason 
why this study designed the first questionnaire which 
owned the characteristic of both Traditional Chinese 
Medicine and modern medicine. This questionnaire was 
Table 2 Characteristics of study participants’ symptoms scale before and after treatment
Symptoms scale Before treatment After treatment
Acupoints herbal  
patching
Placebo P Acupoints herbal  
patching
Placebo P
Detail symptoms—no. (%)
1. Wind intolerance 61 (37) 67 (42) 0.32 13 (11) 13 (11) 0.93
2. Susceptible cold 88 (53) 96 (61) 0.09 16 (13) 10 (8) 0.25
3. Sneeze, running nose before onset 78 (47) 84 (53) 0.29 11 (9) 12 (10) 0.76
4. Onset during quarter turn 122 (74) 114 (72) 0.72 6 (5) 7 (6) 0.73
5. Rapid or difficult breathing 120 (73) 116 (73) 0.89 33 (27) 39 (33) 0.31
6. Wake up by asthma symptoms 113 (68) 110 (70) 0.83 29 (24) 23 (19) 0.42
7. Bluish complexion 24 (15) 17 (11) 0.31 4 (3) 1 (1) 0.19
8. Spontaneous sweating 52 (32) 56 (35) 0.45 6 (5) 10 (8) 0.27
9. Lassitude 95 (58) 86 (54) 0.57 20 (16) 20 (17) 0.91
10. Lack of speech 45 (27) 41 (26) 0.79 9 (7) 8 (7) 0.86
11. Decline in physical strength 79 (48) 66 (42) 0.27 19 (15) 12 (10) 0.21
12. Reduction of exercise 41 (25) 33 (21) 0.40 6 (5) 5 (4) 0.80
13. Lack of strength 91 (55) 90 (57) 0.74 23 (19) 17 (14) 0.36
14. Lack of energy after asthma attack 50 (30) 42 (27) 0.46 6 (5) 5 (4) 0.80
15. Poor appetite 31 (19) 25 (16) 0.48 4 (3) 7 (6) 0.33
16. Abdomen fullness 44 (27) 37 (23) 0.50 5 (4) 6 (5) 0.72
17. Sloopy stool 22 (13) 32 (20) 0.10 5 (4) 6 (5) 0.72
18. Diarrhea after intake of oil food 29 (18) 31 (20) 0.64 3 (2) 3 (3) 0.97
19. Fear of cold 71 (43) 72 (46) 0.65 15 (12) 12 (10) 0.60
20. Soreness and weakness of waist and knees 79 (48) 85 (54) 0.29 9 (7) 15 (13) 0.17
21. Tinnitus 60 (36) 54 (34) 0.68 10 (8) 11 (9) 0.76
22. Frequent urination/night urination 52 (32) 50 (32) 0.98 7 (6) 11 (9) 0.29
23. Redness, hotness or anxiety 58 (35) 53 (34) 0.76 9 (7) 7 (6) 0.65
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Table 4 Symptoms scale at 1st, 2nd, 3rd, and 4th follow ups
Symptoms 
scale
1st follow up 2nd follow up 3rd follow up 4th follow up
Acupoints 
herbal  
patching
Placebo P Acupoints 
herbal  
patching
Placebo P Acupoints 
herbal 
patching
Placebo P Acupoints 
herbal  
patching
placebo P
Detail symptoms—no. (%)
1. Wind intoler-
ance
13 (12) 13 (13) 0.92 9 (10) 4 (5) 0.18 5 (7) 6 (10) 0.55 12 (20) 7 (13) 0.31
2. Susceptible 
cold
18 (17) 17 (17) 0.95 18 (20) 19 (22) 0.74 9 (12) 12 (19) 0.27 15 (25) 20 (37) 0.16
3. Sneeze, 
running nose 
before onset
14 (13) 12 (12) 0.76 7 (8) 16 (18) 0.03 8 (11) 8 (13) 0.73 12 (20) 18 (33) 0.11
4. Onset during 
quarter turn
19 (18) 15 (15) 0.53 11 (12) 14 (16) 0.44 7 (9) 12 (19) 0.11 19 (32) 20 (37) 0.55
5. Rapid or dif-
ficult breathing
33 (31) 22 (22) 0.12 21 (23) 19 (22) 0.84 18 (24) 17 (27) 0.72 22 (37) 27 (50) 0.15
6. Wake up by 
asthma symp-
toms
22 (21) 23 (23) 0.75 13 (14) 24 (27) 0.03 7 (9) 9 (14) 0.38 13 (22) 20 (37) 0.07
7. Bluish com-
plexion
0 (0) 1 (1) 0.31 0 (0) 2 (2) 0.15 2 (3) 1 (2) 0.66 2 (3) 3 (6) 0.56
8. Spontaneous 
sweating
4 (4) 7 (7) 0.32 2 (2) 6 (7) 0.13 0 (0) 5 (8) 0.01 5 (8) 6 (11) 0.62
9. Lassitude 18 (17) 10 (10) 0.13 11 (12) 8 (9) 0.53 12 (16) 7 (11) 0.40 16 (27) 12 (22) 0.58
10. Lack of 
speech
5 (5) 4 (4) 0.78 6 (7) 1 (1) 0.06 2 (3) 2 (3) 0.87 6 (10) 5 (9) 0.89
11. Decline 
in physical 
strength
5 (5) 4 (4) 0.78 7 (8) 4 (5) 0.39 5 (7) 3 (5) 0.62 11 (18) 10 (19) 0.98
12. Reduction of 
exercise
4 (4) 0 (0) 0.05 2 (2) 0 (0) 0.16 1 (1) 2 (3) 0.47 5 (8) 3 (6) 0.56
13. Lack of 
strength
12 (11) 6 (6) 0.17 6 (7) 5 (6) 0.81 9 (12) 2 (3) 0.05 16 (27) 22 (41) 0.11
14. Lack of 
energy after 
asthma attack
4 (4) 4 (4) 0.96 1 (1) 2 (2) 0.53 2 (3) 2 (3) 0.87 4 (7) 6 (11) 0.40
15. Poor appetite 5 (5) 4 (5) 0.78 3 (3) 2 (2) 0.69 2 (3) 3 (5) 0.52 5 (8) 4 (7) 0.86
16.abdomen 
fullness
8 (8) 5 (5) 0.43 4 (4) 1 (1) 0.19 3 (4) 0 (0) 0.11 4 (7) 4 (7) 0.88
17. Sloopy stool 3 (3) 2 (2) 0.69 3 (3) 2 (2) 0.69 2 (3) 5 (8) 0.17 3 (5) 8 (15) 0.08
18. Diarrhea after 
intake of oil 
food
5 (5) 2 (2) 0.27 0 (0) 0 (0) 1.000 0 (0) 2 (3) 0.12 1 (2) 6 (11) 0.04
19. Fear of cold 10 (10) 7 (7) 0.50 5 (5) 7 (8) 0.50 10 (14) 5 (8) 0.30 8 (13) 11 (20) 0.31
20. Soreness 
and weakness 
of waist and 
knees
18 (17) 7 (7) 0.85 4 (4) 2 (2) 0.44 4 (5) 4 (6) 0.81 15 (25) 15 (28) 0.74
21. Tinnitus 12 (11) 8 (8) 0.40 4 (4) 7 (8) 0.31 4 (5) 1 (2) 0.24 12 (20) 12 (22) 0.77
22. Frequent uri-
nation /night 
urination
8 (8) 8 (8) 0.94 5 (5) 1 (1) 0.11 2 (3) 4 (6) 0.30 8 (13) 6 (11) 0.72
23. Redness, hot-
ness or anxiety
6 (6) 6 (6) 0.95 2 (2) 4 (5) 0.38 3 (4) 2 (3) 0.80 3 (5) 6 (11) 0.23
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designed based on both Chinese Medicine and Western 
Medicine experts’ consensus. Inevitably, this self-made 
questionnaire exist some shortcoming and the gap did 
exist between ideal and reality, such as this questionnaire 
only concerned about the asthma-related health care use 
when they had asthma-related symptoms, but didn’t pro-
vide a section to record the detailed medications partici-
pants used, and usage and dosage. Hence, future study 
needed to further improve the quality of this self-made 
questionnaire and to detect its reliability and validity. 
The second limitation was the imperfect blinding. Firstly, 
the smell of real and placebo herbal patch was differ-
ent, even participants didn’t have the chance to see the 
patches, we cannot stop patches’ odor emitted; Secondly, 
participants in acupoints herbal patching group inevi-
tably suffered much greater skin irritations, which will 
easily lead to the failure of blinding when participants 
from real acupoints herbal patching group communi-
cated with placebo group; Thirdly, even participants have 
no idea of acupoints herbal patching before they enter-
ing this study, after joining this study, they might become 
Table 5 Temperature records of Sanfu Days in 2010 [22, 23]
Item timeref 2010
Maximum  
temperature (°C)
Temperature  
(°C)
Minimum  
temperature (°C )
Relative  
humidity (%)
Sun exposure 
(hour)
1st hottest day (July, 19) [22] 33.6 29.7 27.3 77 10.9
2nd hottest day (July, 29) [22] 31.8 28.5 24.5 83 4.6
3rd hottest day (Aug, 8) [23] 32.2 28.8 25.8 84 7.4
Fig. 6 The percentage of participants who didn’t need medical 
treatment when they have a small rise in asthma-related symptoms. 
Acupoints herbal patching was better than placebo in 1st and 3rd 
follow up, P < 0.05
Fig. 7 The percentage of participants suffered from waking up 
by asthma symptoms. Acupoints herbal patching was better than 
placebo in 2nd follow up, P < 0.05
Fig. 8 The percentage of participants suffered from sneeze, running 
nose before asthma onset. Acupoints herbal patching was signifi-
cantly better than placebo in 2nd follow up, P < 0.05
Fig. 9 The percentage of participants suffered from spontaneous 
sweating. Acupoints herbal patching was better than placebo in 4th 
follow up, P < 0.05
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interested in acupoints herbal patching and try to learn 
more about acupoints herbal patching. When partici-
pants know something about acupoints herbal patching, 
they might be easily aware that herbal patches consist of 
irritated ingredients which could incur skin irritations. 
Although blinding existed some inevitable limitations, 
its merits were still worth to be mentioned: firstly, herbal 
patch appearance look almost like placebo patch; sec-
ondary patch applied in the same 11 acupoints; thirdly, 
same duration and both in Sanfu Days. Even the Chinese 
Medicine practitioners have no idea about which group 
they conducted before unblinding. The nearly same 
drop-out rate in post-treatment and four times follow 
ups support that the blinding of this study was relatively 
successful. And after treatment, both groups got a signifi-
cant improvement comparing with the baseline. All these 
show that placebo effect did exist during treatment and 
most participants in placebo group believed that they had 
received the real treatment.
β-agonists, which are the most common drug treat-
ment during acute asthma attack while are associated 
with various adverse effects [4, 5]. In this study, the sta-
tistical results showed that the proportion of participants 
who didn’t need to use pharmaceutical treatment when 
they have a small rise in asthma-related symptoms was 
significantly increased after acupoints herbal patching. 
Besides, adverse events in this study were very minor, and 
the morbidity of side-effects in acupoints herbal patch-
ing group was insignificant higher than placebo group. 
TCM considerate that Sanfu Days are the three hottest 
in a year and both Yang-qi of body and nature are most 
exuberant in these days. From the temperature record of 
2010, it was found that the average temperature in Sanfu 
Days from July 19, 29 and August 8 in 2010 (Table 5) was 
pretty high, all of them were above 31  °C, air humidity 
was above 77  %, and sunshine duration was more than 
4.6 h [25, 26]. Hence, acupoints herbal patching in Sanfu 
days might be recommend as a complementary preven-
tive treatment for chronic stable asthma especially for 
Qi-deficiency and Yang-deficiency patients.
Conclusions
There was no significant difference between acupoints 
herbal patching and placebo group at the end of 3rd treat-
ment and four times follow ups in pulmonary function 
test. The result was different from Li YH’s clinical stud-
ies about acupoints herbal patching for asthma, which 
show that acupoints herbal patching can significantly 
improve participants’ lung function [27]. Also, the sec-
ondary outcome of acupoints herbal patching group was 
no significant difference as compare with placebo group. 
However, the sub-analysis of secondary outcomes in the 
four times follow ups show that as time goes on, the last-
ing effect of acupoints herbal patching was superior to 
placebo especially in improving Lung-qi-deficiency and 
Fig. 10 The percentage of participants susceptibly suffered from 
diarrhea after intake of oily food. Acupoints herbal patching was bet-
ter than placebo in 4th follow up, P < 0.05
Fig. 11 Asthma attack time distribution diagram
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Spleen-qi-deficiency syndromes. What’s more, the last-
ing effect of acupoints herbal patching was better than 
placebo in reducing medication need when they had 
a small rise in asthma-related symptoms. Acupoints 
herbal patching will not only be a significant alternative 
treatment with a low risk of side effect for asthma par-
ticipants, but also provide a good choice for health policy 
makers.
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